INVO Fertility (NASDAQ:IVF – Get Free Report) and Nutex Health (NASDAQ:NUTX – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, analyst recommendations, risk, dividends and valuation.
Profitability
This table compares INVO Fertility and Nutex Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| INVO Fertility | -116.29% | -85.54% | -31.05% |
| Nutex Health | 21.25% | 39.74% | 18.91% |
Volatility & Risk
INVO Fertility has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500. Comparatively, Nutex Health has a beta of 0.28, meaning that its stock price is 72% less volatile than the S&P 500.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| INVO Fertility | 1 | 0 | 0 | 1 | 2.50 |
| Nutex Health | 0 | 1 | 2 | 1 | 3.00 |
INVO Fertility presently has a consensus target price of $20.00, suggesting a potential upside of 1,914.10%. Nutex Health has a consensus target price of $317.50, suggesting a potential upside of 51.88%. Given INVO Fertility’s higher possible upside, equities research analysts plainly believe INVO Fertility is more favorable than Nutex Health.
Insider & Institutional Ownership
12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 0.4% of INVO Fertility shares are owned by company insiders. Comparatively, 44.7% of Nutex Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Earnings & Valuation
This table compares INVO Fertility and Nutex Health”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| INVO Fertility | $6.84 million | 0.36 | -$25.13 million | ($33.83) | -0.03 |
| Nutex Health | $875.26 million | 1.64 | $70.79 million | $25.47 | 8.21 |
Nutex Health has higher revenue and earnings than INVO Fertility. INVO Fertility is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.
Summary
Nutex Health beats INVO Fertility on 11 of the 14 factors compared between the two stocks.
About INVO Fertility
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
About Nutex Health
Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.
Receive News & Ratings for INVO Fertility Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Fertility and related companies with MarketBeat.com's FREE daily email newsletter.
